Hirokazu Okamoto

2.9k citations
112 papers · 2.4k indexed · h-index 31
Topics
Inhalation and Respiratory Drug Delivery (48 papers)Drug Solubulity and Delivery Systems (25 papers)Advanced Drug Delivery Systems (22 papers)
Partner nations
JapanSwitzerlandChina

In The Last Decade

Hirokazu Okamoto

108 papers receiving 2.3k citations

Peers

Hirokazu Okamoto
Comparison fields: 5 of 125
  • Pharmaceutical Science 1.2k
  • Pulmonary and Respiratory Medicine 1.0k
  • Food Science 590
  • Molecular Biology 565
  • Biomedical Engineering 235
Replace Yuh‐Fun Maa with:
Yuh‐Fun Maa United States
Rita Vanbever Belgium
C Marriott United Kingdom
Christopher Marriott United Kingdom
Stuart A. Jones United Kingdom
Abdolhossein Rouholamini Najafabadi Iran
Alessandra Rossi Italy
Rakesh Patel United States
Dongmei Cun China
Hartwig Steckel Germany
Hirokazu Okamoto relative to Yuh‐Fun Maa United States Yuh‐Fun Maa's profile →
Citations per field
00.5×1.5×
Yuh‐Fun Maa · 1×
Citations per year

Countries citing papers authored by Hirokazu Okamoto

Since Specialization
Citations

This map shows the geographic impact of Hirokazu Okamoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hirokazu Okamoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hirokazu Okamoto more than expected).

Fields of papers citing papers by Hirokazu Okamoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hirokazu Okamoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hirokazu Okamoto. The network helps show where Hirokazu Okamoto may publish in the future.

Co-authorship network of co-authors of Hirokazu Okamoto

This figure shows the co-authorship network connecting the top 25 collaborators of Hirokazu Okamoto. A scholar is included among the top collaborators of Hirokazu Okamoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hirokazu Okamoto. Hirokazu Okamoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 1
4 4
5 16
6 9
7 14
8 1
9 3
10 68
11 1
12 3
13 3
14 49
15 100
16 38
17 37
18 23
19
Structure and Expression of Human Vasoactive Intestinal Peptide/PHM-27 Gene
1
20
The studies about parasite control in rural areas in Japan; the new type of pit privy to separate urine and stool.
1

About Hirokazu Okamoto

Hirokazu Okamoto is a scholar working on Pharmaceutical Science, Pulmonary and Respiratory Medicine and Microbiology, having authored 112 papers that have together received 2.4k indexed citations. Recurring topics across this work include Inhalation and Respiratory Drug Delivery (48 papers), Drug Solubulity and Delivery Systems (25 papers) and Advanced Drug Delivery Systems (22 papers). The work is most often cited by research in Pharmaceutical Science (1.2k citations), Food Science (590 citations) and Pulmonary and Respiratory Medicine (1.0k citations). Hirokazu Okamoto has collaborated with scholars based in Japan, Switzerland and China. Frequent co-authors include Kazumi Danjo, Kotaro Iida, Mitsuru Hashida, Tomoyuki Okuda, Hiroaki Todo, Hitoshi Sezaki, Hans Leuenberger, Hideo Komatsu, Hitoshi Sezaki and Kohta Mohri. Their work appears in journals such as Advanced Drug Delivery Reviews, Scientific Reports and Journal of Controlled Release.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026